Iโm extremely honored to have been chosen as one of this yearโs STAT Wunderkinds and grateful for the incredible support of my mentors @ashunephro.bsky.social and Sus Waikar!! @bu_bmc_renal ๐ #nephsky
www.statnews.com/wunderkinds/
@ashunephro.bsky.social
Clinician Scientist at Boston University Chobanian & Avedisian School of Medicine. Nephrologist at Boston Medical Center and BU Amyloidosis center https://profiles.bu.edu/Ashish.Verma
Iโm extremely honored to have been chosen as one of this yearโs STAT Wunderkinds and grateful for the incredible support of my mentors @ashunephro.bsky.social and Sus Waikar!! @bu_bmc_renal ๐ #nephsky
www.statnews.com/wunderkinds/
Foot Process Effacement (FPE) could serve as a valuable marker for assessing the risk of disease progression across various kidney pathologies. Read more in #ASNKidney360: kidney.pub/KID0894
@ashunephro.bsky.social @sophieclaudel.bsky.social
Our article,ย โCumulative Incidence of Mortality Associated with CardiovascularโKidneyโMetabolic (CKM) Syndrome,โย published inย JASN @sophieclaudel.bsky.social  @asnpublications.bsky.social 
has been selected for theย โBest of ASN Journals at KidneyWeek 2025. journals.lww.com/jasn/fulltex...
Despite repeating proteinuria measurements throughout a patient with CKD's clinical course, clinicians may overlook important temporal patterns that emerge. Read more about proteinuria trajectories and risk of adverse clinical outcomes: kidney.pub/KID0849 #ASNKidney360 @ashunephro.bsky.social
Milestone release of #rstats rms package is now on CRAN with a full suite of survival analysis fitting, validation, and graphical display functions based on semiparametric models, generalizing the Cox PH model to a spectrum of models including accelerated failure time. hbiostat.org/r/rms #StatsSky
15.04.2025 15:11 โ ๐ 41 ๐ 8 ๐ฌ 0 ๐ 1Excited to share our comprehensive review โCardiovascular-Kidney-Metabolic Health: Definition, Staging, Risk Assessment, and Therapeutic Considerationsโ #CardiologyClinics @sophieclaudel.bsky.social @ahascience.bsky.social 
@asnkidney.bsky.social 
kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F...
Genetic Testing in Biopsy-Confirmed Kidney Disease
05.04.2025 15:52 โ ๐ 6 ๐ 4 ๐ฌ 0 ๐ 0Cardiovascularโkidneyโmetabolic (CKM) syndrome stages 1 to 4 are associated with a graded risk of cardiovascular mortality in a nationally representative sample of U.S. adults. https://bit.ly/JASN0637 
#ASNJASN
@ashunephro.bsky.social
@sophieclaudel.bsky.social
Cumulative Incidence of Mortality (CKM) syndrome stages 1 to 4 are associated with a graded risk of cardiovascular mortality in a nationally representative sample of U.S. adults. https://bit.ly/JASN0637 
#ASNJASN
@ashunephro.bsky.social
@sophieclaudel.bsky.social
Learned quite a lot about interactions, thresholds, and synergistic effects from @ashunephro.bsky.social in this analysis of albuminuria, heart failure, and CKD progression. Our findings emphasize albuminuria as a key biomarker for CKM health. ๐ซ
@jaccjournals.bsky.social #NephSky
Delighted to share our study published in @jaccjournals.bsky.social  led by @sophieclaudel.bsky.social.  We demonstrated deleterious synergy between albuminuria and heart failure as risk factors for CKD progression. 
www.jacc.org/doi/10.1016/...
Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review ca. 2025 
#Nephpearls #NephSky 
๐๐ผ pubmed.ncbi.nlm.nih.gov/40063723/
Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review ๐ฉโ๐ฌ๐ฅผ๐งช๐จโ๐ฌ #CardioSky #NephSky #cardiovascular #cardio-renal #metabolicdisorder #KidneyResearch #kidneydisease ๐๐๐
www.ahajournals.org/doi/epub/10....
Please let me know your email id.
12.03.2025 17:15 โ ๐ 0 ๐ 0 ๐ฌ 1 ๐ 0Send me your email id.
12.03.2025 17:14 โ ๐ 0 ๐ 0 ๐ฌ 1 ๐ 0Extremely grateful to @ahascience.bsky.social and @ashunephro.bsky.social for the opportunity to publish this comprehensive review on albuminuria in #Circulation. We cover albuminuria in the spectrum of #CKM disorders. Please take a look! 
@nephjc.bsky.social #NephSky
Thank you for highlighting our review!!!
10.03.2025 20:10 โ ๐ 3 ๐ 0 ๐ฌ 0 ๐ 0Thrilled to share our state of art review  led by extraordinary @sophieclaudel.bsky.social 
โAlbuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review"
www.ahajournals.org/eprint/SXXGK...
@ahascience.bsky.social 
@ahajournals.bsky.social 
@asnkidney.bsky.social
Excited to share this research letter looking at albuminuria values in healthy adults! We followed IFCC guidelines for establishing references ranges, which had not previously been shown in the literature, and consider what โnormalโ should be by sex.
22.02.2025 13:20 โ ๐ 1 ๐ 1 ๐ฌ 0 ๐ 0We sought to quantify the upper limit of normal for albuminuria among US adults by the IFCC standard. Our study led by @sophieclaudel.bsky.social โAlbuminuria References Ranges in Healthy US Adultsโ 
academic.oup.com/jalm/advance...
Thrilled to share our publication led by exceptional @sophieclaudel.bsky.social "Cumulative Incidence of Mortality Associated with Cardiovascular-Kidney-Metabolic Syndrome" in @asnpublications.bsky.social journals.lww.com/jasn/abstrac... @asnkidney.bsky.social @americanheart.bsky.social
11.02.2025 17:38 โ ๐ 2 ๐ 1 ๐ฌ 0 ๐ 1Our comprehensive review on โ Diuretics in patients with chronic kidney diseaseโ @natrevneph.bsky.social
07.01.2025 18:31 โ ๐ 7 ๐ 3 ๐ฌ 0 ๐ 0Adults with higher levels of albuminuria within the low range (UACR <30 mg/g) and no major cardiovascular risk factors have higher risks of cardiovascular and all-cause mortality. academic.oup.com/eurjpc/artic... @sophieclaudel.bsky.social
06.01.2025 02:22 โ ๐ 5 ๐ 0 ๐ฌ 0 ๐ 1Very excited to share this work by my mentor Dr. Ashish Verma and me on #SDOH and #mortality among adults *without* major chronic diseases published in @JGIM! We looked at food insecurity, employment, income, acculturation, education and healthcare access. 
link.springer.com/article/10.1...